Reply to the diagnostic conundrum of bacterial infections in cirrhotic patients.
Sign Up to like & getrecommendations! Published in 2017 at "Liver International"
DOI: 10.1111/liv.13474
Abstract: To the Editor: We would like to respond to Scott et al. and the accompanying editorial.1,2 Concentrated factor products like recombinant activated factor VII (NovoSeven®; Novo Nordisk Pharmaceuticals Inc., Bagsværd, Denmark) and prothrombin complex concentrate… read more here.
Keywords: infections cirrhotic; reply diagnostic; bacterial infections; cirrhotic patients ... See more keywords